Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
Défaillance Cardiovasculaire Aiguë et Chronique · Harvard University · +10 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
754
total citations
- FWCI
- 80.63
- Percentile
- 100%
- References
- 37
Citations per year
Authors
12- FZFaı̈ez ZannadCorresponding
Défaillance Cardiovasculaire Aiguë et Chronique
- CPChristopher P. Cannon
Harvard University, Brigham and Women's Hospital
- WCWilliam C. Cushman
Memphis VA Medical Center, University of Tennessee at Knoxville, University of Tennessee Health Science Center
- GLGeorge L. Bakris
University of Chicago
- VMVenu Menon
Cleveland Clinic
Topics & keywords
Topics
Keywords
- Alogliptin
- Medicine
- Heart failure
- Mace
- Myocardial infarction
- Internal medicine
- Placebo
- Hazard ratio
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.